The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Innate immune memory in the brain shapes neurological disease hallmarks
Open accessAbstract
Innate immune memory is a vital mechanism of myeloid cell plasticity that occurs in response to environmental stimuli and alters subsequent immune responses. Two types of immunological imprinting can be distinguished-training and tolerance. These are epigenetically mediated and enhance or suppress subsequent inflammation, respectively. Whether immune memory occurs in tissue-resident macrophages in vivo and how it may affect pathology remains largely unknown. Here we demonstrate that peripherally applied inflammatory stimuli induce acute immune training and tolerance in the brain and lead to differential epigenetic reprogramming of brain-resident macrophages (microglia) that persists for at least six months. Strikingly, in a mouse model of Alzheimer's pathology, immune training exacerbates cerebral β-amyloidosis and immune tolerance alleviates it; similarly, peripheral immune stimulation modifies pathological features after stroke. Our results identify immune memory in the brain as an important modifier of neuropathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Next we tested the effect of Aβ42 and LPS on oxidative stress response in microglial cells as amyloid and inflammation trigger and exacerbate pathological changes in AD brain (Wendeln et al., 2018).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Wendeln et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“peripheral insults that cause a systemic inflammatory response might affect ongoing inflammation in the CNS mainly by microglial activation, production of inflammatory molecules, as well as recruitment of peripheral immune cells into the brain, thus shaping a cerebral inflammatory milieu that may seriously affect neuronal function (50, 52, 53).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [53]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, nonspecific microglia activation induced by lipopolysaccharide does not have the same amyloid-promoting effect as myelin dysfunction, as increases, decreases or no changes in amyloid burden have been reported48–51.”
From Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease (2023) · cites this paper as [49]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A Hif1a epigenetic and transcriptomic signature was recently identified in microglia following immune training by peripheral LPS administration in APP/PS1 mice65.”
From Transcriptional signature in microglia associated with Aβ plaque phagocytosis (2021) · cites this paper as [65]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Animal and in-vitro studies demonstrate that inflammatory stimuli may initiate long-term priming of the microglia, peripheral CD4+ and CD8+ T cells to a proinflammatory state, (352-354) potentially increasing amyloid plaque deposition.(355)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [355]
The cited source says what the claim attributes to it.
In the citing paper
“Our data suggest that PU.1 may contribute to this mechanism of innate immune memory in the brain (Wendeln et al., 2018).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Wendeln et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“although it is important to note that the efficiency of individual phagocytic processes can be dependent on experimental conditions65–67.”
From Transcriptional signature in microglia associated with Aβ plaque phagocytosis (2021) · cites this paper as [65]
The cited source says what the claim attributes to it.
In the citing paper
“We found little overlap between the Hif1a module reported in65 and the Hif1a regulon identified here (Supplementary Fig. 13d)”
From Transcriptional signature in microglia associated with Aβ plaque phagocytosis (2021) · cites this paper as [65]
The cited source says what the claim attributes to it.
In the citing paper
“In healthy mice, peripherally applied LPS can differentially reprogram the epigenome of microglia by inducing either acute immune training or tolerance pending upon the number of injections [102].”
From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [102]
In the citing paper
“and systemic endotoxin precipitates brain pathology in mice expressing prions [74], APP variants [33] or TAU variants [69] or mice with α-synuclein injected in the brain [46].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [33]
In the citing paper
“Microglial markers such as purinergic receptor P2Y G-protein coupled 12 (P2ryl2), transmembrane protein 119 (Tmem119), and Fc receptor-like S, scavenger receptor (Fcrls), are used to define microglia homeostatic state.”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [11]
In the citing paper
“Whereas, inflammatory marker Clec7a is used to define microglia in neurodegenerative state [11].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [11]
In the citing paper
“Immune memory in microglia and macrophages are shaped by epigenetically mediated alterations in the enhancer repertoire of targeted genes [11, 32].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [11]
In the citing paper
“In addition, APP mice with four-time LPS treatment showed increased H3K4me1 levels in putative enhancers related to phagocytic function [11].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [11]
In the citing paper
“Cerebral beta-amyloidosis activates HIF-1a and mTOR pathways, which leads to transcriptional and functional alterations associated with increased inflammatory and immune response genes in MGnD [11].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [11]
In the citing paper
“Peripheral immune stimulation and cerebral beta-amyloidosis can lead to epigenetic modification in microglia.”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [11]
In the citing paper
“These data suggest the differential effect of immune training versus tolerance due to multiple peripheral immune stimulation, which is reflected in the epigenetic landscape of MGnD in AD mouse models.”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Full-length RNA-seq from single cells using Smart-seq2
Picelli, S., Faridani, O. R., Björklund, Å. K., Winberg, G., Sagasser, S., & Sandberg, R. (2014) · Nature Protocols · doi:10.1038/nprot.2014.006 · Cited by 4,137
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979
Trained immunity: A program of innate immune memory in health and– disease
Netea, M. G., Joosten, L. A. B., Latz, E., Mills, K. H. G., Natoli, G., Stunnenberg, H. G., O’Neill, L. A. J., & Xavier, R. J. (2016) · Science · doi:10.1126/science.aaf1098 · Cited by 2,768
The immunology of stroke: from mechanisms to translation
Iadecola, C., & Anrather, J. (2011) · Nature Medicine · doi:10.1038/nm.2399 · Cited by 2,596
Mills, E. L., Kelly, B., Logan, A., Costa, A. S. H., Varma, M., Bryant, C. E., Tourlomousis, P., Däbritz, J. H. M., Gottlieb, E., Latorre, I., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.064 · Cited by 2,291
Cited by
Sorted by citations
Items 901–969 of 969
Han, Y., Lee, H., Sim, S.-J., Han, D.-M., Kim, S.-Y., Lee, R., Jeon, Y., Kim, H., Park, J., Randolph, G. J., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8451576/v1
Bibliometric and Visual Analysis of Trained Immunity from 2005 to 2024
Yang, Z., Hu, J., Kang, L., & He, H. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s561807
Infectious vs. Sterile Neuroinflammation: Differential Consequences on Neuronal CircuitryPreprint
Talero-López, D. (2026) · Qeios · doi:10.32388/1h63qt
Al-Maphregy, G. A. A., Alabassi, H. M., & Hussein, A. A. (2026) · Journal of Parasitology Research · doi:10.1155/japr/8684617
“Even with repeated low doses of LPS, systemic administration of LPS causes body weight loss in experimental animals [13].”
Nicolas, S., & Nolan, Y. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00003-6
Kodali, M. C., Wang, Z., Lin, G., & Liao, F. (2026) · Research Square · doi:10.21203/rs.3.rs-8844780/v2
Intranasal HSV-1 Infection Drives Region-Specific Interferon-Dominant Microglial RemodelingPreprint
Frietze, S. E., Lunn, C., Oldham, D., Boyd, J. R., Bubak, A. N., Bustillos, A., Nagel, M. A., Restrepo, D., Bruce, K. D., & Niemeyer, C. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.13.711627
INTERPLAY BETWEEN GUT MICROBIOTA AND NEURODEGENERATION
Yusupov, F. A., & Abdykadyrov, M. S. (2026) · Avicenna Bulletin · doi:10.25005/2074-0581-2026-28-1-162-173
Rôle du récepteur 5-HT2B dans la motilité des cellules microgliales
Etienne, F. (2020) · theses.fr (ABES) · doi:10.70675/525a2c9ez9415z45f8z8838z1155f108aaf2
Étude moléculaire de l'inflammation chronique dans la maladie de Parkinson
Compagnion, A. (2019) · theses.fr (ABES) · doi:10.70675/04ca138dz3131z4e24z884czbba2f7954a99
MafB and c-Maf transcriptional control of macrophage self-renewal and activation
Huang, H. (2021) · theses.fr (ABES) · doi:10.70675/e3a80f7dz82c4z4f22z8b5eze5bb96e6bf01
Impact of Listeria monocytogenes on microglia and cerebral homeostasis
Levallois, S. (2023) · theses.fr (ABES) · doi:10.70675/cf058269z5911z4582z94fezcb6761f74ddd
Feraoun, G. N. Y. (2022) · theses.fr (ABES) · doi:10.70675/e8e7fd4azd930z4307zad62z2c0404a8d331
Exploration et modulation de l'immunité entrainée au cours de l'athérosclérose expérimentale
Lavillegrand, J. (2022) · theses.fr (ABES) · doi:10.70675/57d04b05za207z47faz8466z03904c89430b
Mesaoudi, A. E. (2024) · theses.fr (ABES) · doi:10.70675/f339157ez1688z4acaz87fcz0ecae062a7cc
Liu, N., Yan, L., Ye, M., Huang, C., 李琪, Lu, X., Yang, R., Gu, J., Wang, H. W., & Tong, L. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178848
Vagus nerve stimulation modulates LPS-induced epileptogenicity: the role of inflammation suppressionPreprint
Lawlor, G. L., Khan, S., Asimakopoulos, T., Sinha, I. R., Ling, J., Irazoqui, P. P., Alexandris, A. S., & Koliatsos, V. E. (2026) · Research Square · doi:10.21203/rs.3.rs-8896240/v1
Translational evidence for increased central amygdala IL-6 activity in alcohol dependence
Onge, C. M. S., Erikson, C. M., Cruz, B., Borgonetti, V., Hashimoto, J. G., Cucinello‐Ragland, J. A., Fitzpatrick‐Schmidt, T., Rodriguez, L., Khom, S., Palmisano, M., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03868-2 · Cited by 1
“Overall, our transcriptomic analyses of human CeA indicate that individuals with AUD exhibit a generalized neu-roimmune activation that includes both neuronal and glial immune signaling consistent with similar findings across other neurodegenerative conditions [100–103].”
Dong, L., Doorduin, J., & de Vries, E. F. J. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106771
Lawrence, E., Fulton, D. J., Brown, P., Suresh, S., Morris, D. M., Goggolidou, P., Chaithanya, S., Abbawy, M., Wild, A., Nasa, P., et al. (2026) · Brain and Behavior · doi:10.1002/brb3.71542
Neuroinflammation, Glia–Neuron Crosstalk, and Energy Metabolism in Alcohol Use Disorder
Skryabin, V. Y., Sokolova, S. I., & Masyakin, A. V. (2026) · Biochemistry (Moscow) · doi:10.1134/s0006297925604149
“With priming, the activation threshold of cells decreases, leading to an enhanced response to subsequent exposure [19].”
Recent Advances in Epigenetic Signatures of Nanomaterial Exposure Linked to Neurotoxicity
Liu, K., & Wu, T. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70319
Thymus-derived myeloid programs track microglial tolerance states across human cohorts
Zafar, S. A., Qin, W., Liu, C. X., Khan, A. A., & Faisal, M. S. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106221
Giacovazzo, G., Latina, V., Yurtsever, Z. N., Piccolino, I., Iannuzzi, F., Bossù, P., Amadoro, G., & Coccurello, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1845312
“…used to study the brain ’ s response to systemic immune challenges (31, 32), evokes a primed immune state in microglia from APP23 (APP751Swedish double mutation (K670M/N671L)) AD mice and signi fi cantly in fl uences their neuropathology later in life by increasing cerebral b -amyloidosis (33).”
Luo, X., Wickman, J. R., DaCunza, J., Tian, Y. Z., Saçan, A., & Ajit, S. K. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s598095
“14,15 Collectively, these persistent enhancer and promoter”
Brain network alterations in autoimmune diseases: Current status and future prospects
Lee, X. N., Zhang, H., & Zhou, H. (2026) · iScience · doi:10.1016/j.isci.2026.116682
“102 Circulating cytokines such as interleukin-1 β and tumor necrosis factor-α further contribute to cognitive impairment and altered network dynamics by inducing sickness behaviors and disrupting neuronal signaling.”
Infectious vs. Sterile Neuroinflammation: Differential Consequences on Neuronal CircuitryPreprint
Talero-López, D. (2026) · Qeios · doi:10.32388/1h63qt.3
Jiang, H., Gao, P.-P., Du, Y., Wu, L.-C., Yin, E., An, Q., Ding, Z.-H., Shi, J., Shu, Y., Chen, R., et al. (2026) · Advanced Science · doi:10.1002/advs.76690
“Notably, transcription factors from the IRF and NF-κ B families—key regulators of IIM [ 23, 25, 50 ]—were significantly upregulated in Csmd3 + microglia from ICu mice (Figure 3F,G ).”
Aktar, A., Ferdiousi, N., Rahman, M. M., Hossain, M. S., Islam, F., Roy, D. N., & Mazumder, K. (2026) · BioChem · doi:10.3390/biochem6030023
“…target genes represents another emerging strategy, wherein drugs that modulate histone acetylation or DNA methylation at specific gene promoters may selectively enhance or suppress the expression of HIF-1 target genes that mediate beneficial effects without affecting pathogenic target genes [107].”
Horvath, M., & Imitola, J. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.579049
Giffin, K. A., Puranik, N., Bustamante, A. C., Padilla, M., Zeng, Z., Randolph, G., Wheaton, L., Moore, S. J., Newstead, M. W., Denstaedt, S. J., et al. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101309
“Some literature suggests that systemic infection promotes neuroinflammation and accelerates Alzheimer's disease neuropathology (Gasparotto et al., 2018; Heneka et al., 2025; Itzhaki et al., 2020; Wendeln et al., 2018).”
Lajqi, T., Köstlin‐Gille, N., Birdir, C., Hebel, J., Miftari, I., Bauer, R., Zarogiannis, S. G., Funaya, C., Gille, C., & Dietz‐Ziegler, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1858954
Bao, Y., Chen, Z., & Jia, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1893074
“Wendeln et al. showed that peripheral in fl ammatory stimulation leaves a long-lasting epigenetic imprint on microglia, producing either trained immunity or tolerance in subsequent neurological disease models (27).”
Adams, J. R. G., Anjum, F. R., Abare, M. Y., Mehat, J. W., Ragione, R. L., & Behboudi, S. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag209
Exendin-4 as a multi-target therapy for Fetal Inflammatory Response Syndrome-induced brain injury
Li, S., Cai, C., & Arigong, G. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1848474
Molecular memory of cell fate: A missing dimension of neural implant biocompatibility
Xie, M. F. M., Tebak, R. R., Pathak, A., Tiwari, V., & Glass, C. K. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20261285
León‐Rodríguez, A., Wangler, L. M., Goodman, E., Packer, J. M., Davis, A., Sheridan, J. F., Grondona, J. M., Godbout, J. P., & López-Ávalos, M. D. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106963
Wang, H., Zhu, Z., Yin, Z., Geng, Y., Xu, Y., Fan, Y., & Zhang, K. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02412-w
“While short-term HIF1A activation might promote phagocytosis and induce trained immune memory [40, 64], our in vitro double-hit model showed that hypoxia combined with α-Syn load leads to p62 accumulation—a failure of cargo receptor degradation [25]—and impaired autophagy-related protein handling.”
Peng, Y., Jin, C. J., Sun, Y., Mu, W., & Zheng, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1898176
Valladares, K. N., Fields, J. L., Katz, J., Michalek, S. M., & Zhang, P. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177665
“In microglia, immune training is typically characterized by amplified inflammatory signaling, increased phagocytic activity, and enhanced clearance of pathogens and debris [11].”
InfluentialConvergent Innate Immune and Metabolic Signatures in Parkinson’s Disease and Viral InfectionPreprint
Belyea, M. M., Shafiq, M., Laß, J., Much, C., Liu, Z., Kruse, N., Haendler, K., Sreenivasan, V., Gelpí, E., Siebels, B., et al. (2026) · medRxiv · doi:10.64898/2026.08.28.26361092
Targeting of NLRP3 Gln624/Ser658 by Carabrone attenuates inflammatory diseases
Jia, B., Abuduwaili, Z., Tang, H., Xiao, J., Zhang, R., Bao, X., Chen, J., Deng, S., Xu, Y., Yu, L., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179299
Papait, A., Natale, F., Silini, A. R., Sarrapochiello, I. N., Orecchini, E., Sollazzo, R., Rinaudo, M., Farigu, S., Garofalo, N., Mantini, G., et al. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00581-1
“More broadly, the EV cargo might promote innate immune tolerance rather than innate immune training (i.e., the pro-inflammatory memory phenotype of primed microglia) in microglia, an imprinting reported to alleviate β-amyloidosis [58].”
Ullah, A., & Zaman, W. (2026) · Immunologic Research · doi:10.1007/s12026-026-09845-4
“These human atlases complement experimental evidence for microglial innate memory [50, 62], but they should be interpreted as state maps rather than direct demonstration of trained immunity unless prior exposure, durability, and altered recall can be established.”
Pharmacological control of inflammation via innate immune memory manipulation
Sharma, C., Sharma, S., & Gupta, S. (2026) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2026.102675
Deckers, J., van Elsas, Y., Versteeg, I., Anbergen, T., Toner, Y. C., Grao-Roldán, C., Cole, J. E., Umali, M., Wang, W., Nauta, S. A., et al. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101660
Chen, Y., Li, S., Lin, H., Zou, F., & Wang, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1936082
“In fl ammatory-memory and neurodegeneration models show how immune responses can remain altered after the initiating challenge (70, 74).”
Li, X., Rong-liang, G., Teng, Z., Liu, P.-P., & Liu, C. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103377
Mingke, T., Li, J., Zhang, C., Tu, R., & Wang, S. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1973833
“Microglial innate memory provides a parallel CNS concept (Wendeln et al., 2018).”
InfluentialYue, H., Lu, J., Yasha, Z., Xiao, L., Deng, Y., Peng, Q., & Yang, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1958864
“Innate immune memory in microglia has also been demonstrated in other central nervous system settings (76).”
Emmerson, J. T., Hu, H., Savani, V., Lin, P. B., Rohde, M., Sharma, P., Self, W. K., Li, Y., Nulman, J., Bosch, M. E., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.08.030
Zhang, E., Sha, L., Zhu, C., Zhou, Z., Jin, Z., Yu, X., Meng, P., Meng, K., Wei, H., & Xu, Q. (2026) · Immunity & Inflammation · doi:10.1007/s44466-026-00054-0
Rethinking the Oligodendrocyte Progenitor Cell: One Cell, Many Functions
de la Fuente, A. G. (2026) · European Journal of Neuroscience · doi:10.1111/ejn.70676
Before the insult: Why the microglial starting state matters in neurodegeneration
Szelechowski, M. (2026) · Glial health research. · doi:10.1016/j.ghres.2026.100022
Chen, Y., Li, F., Junlei, Z., 魏明清, 倪敬年, Li, T., Yao, L., Tian, J., & Shi, J. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71909
“109 In a Parkinson’s disease model, microglia-specific deletion of HIF-1 α blocks immune memory and reduces pathology.”
He, Q.-L., Hu, X.-Y., Deng, Y.-L., Wu, H.-P., Zhu, S.-Y., Gu, H., Yang, J.-J., & Ji, M. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.107065
Architect or Destroyer: The Diversity of Glucocorticoid Receptor Signaling Pathways in the Brain
Shkarina, L. N., Khaybullina, R., Primak, A. L., Дмитриевич, Б. К., Станиславович, Д. С., & Karagyaur, M. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209027
VZV reactivation, immune remodeling, and dementia risk
Zhang, L., Wu, S., Quan, Y., & Yao, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1953013
The Role of Astrocytes in the Inflammatory Response in Neurodiseases
Peng, S., Wang, L., Ouyang, J., & 刘如恩 (2026) · MedComm · doi:10.1002/mco2.71069
“…inflammatory responses are not only rapidly activated by transient signals but are also profoundly regulated by epigenetic mechanisms, which provide a form of “molecular memory,” enabling differentiated responses to prior stimuli, i.e., forming “trained immunity” or “immune tolerance” [ 245– 247 ].”
Li, F., Ye, M., Tong, L., Huang, C., Xu, X., & Peng, J. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04915-3
“This tolerized state is sustained by epigenetic reprogramming of innate immune effector cells, including microglia, resulting in reduced pro-inflammatory cytokine production upon re-stimulation [ 14, 15].”
Zhao, X., He, J., Yu, W., Lin, H., He, Q., Zhenyan, S., & Cheng, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06281-1
“In APP23 mice, peripheral LPS exposure reshapes microglial immune states and thereby influences Aβ pathology and injury responses [30].”
Liu, X., Wang, S., Long, W., Tan, X., Li, W., & Gao, L. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1926883
da Cruz, R. S., Lopes, L. S., Pachiega, A. N. S., Colombari, D. S. A., Colombari, E., Zoccal, D. B., & Katayama, P. L. (2026) · Inflammation Research · doi:10.1007/s00011-026-02401-8
“In amyloid models, peripheral inflammatory stimulation durably repro - grams microglia — acute stimulation ‘training’ and repeated stimulation ‘tolerizing’ subsequent responses — and these opposite imprints measurably alter amyloid pathology months later [97].”
Li, J., Ye, M., Lu, X., Dai, Q., Huang, C., & Peng, J. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04934-0
“However, microglia in the central nervous system may exhibit different kinetics due to lower turnover rates and distinct epigenetic regulation [ 36].”
Jiahui, Z. H. O. U., Wang, J., Li, X., Dou, J., Chen, S., & Xue, F. (2026) · Life · doi:10.3390/life16111808
Zhang, Y., Chen, Y., Cheng, Y., Li, R., Chen, W., Li, Y., Fan, Q., Zhou, Y., Huang, T., Xie, W., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02482-y
Gao, C., Shi, R., Jiang, X., Chai, H., & He, X. (2026) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2026.126237
Metadata
- Authors
- Wendeln, A.-C., Degenhardt, K., Kaurani, L., Gertig, M., Ulas, T., Jain, G., Wagner, J., Häsler, L. M., Wild, K., Skodras, A., Blank, T., Staszewski, O., Datta, M., Centeno, T. P., Capece, V., Islam, M. R., Kerimoglu, C., Staufenbiel, M., Schultze, J. L., Beyer, M., Prinz, M., Jucker, M., Fischer, A., & Neher, J. J.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- University of Bonn (DE)
- University of Freiburg (DE)
- Corresponding author
- Neher, Jonas J.
- ORCID
- Venue
- Nature
- Published
- 2018-04
- Volume
- 556
- Issue
- 7701
- Pages
- 332-338
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6038912
- OpenAlex
- W2796983933
- Cited by
- 956
- References
- 51
- Citations by year
- 2026: 117 · 2025: 102 · 2024: 120 · 2023: 106 · 2022: 121 · 2021: 135 · 2020: 104 · 2019: 90 · 2018: 60
- FWCI
- 43.97
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- trained immunity, immunological imprinting, immune tolerance, microglia, epigenetic reprogramming, neuroinflammation, Alzheimer's disease, beta-amyloidosis, stroke, neuropathology
- MeSH terms
- Alzheimer Disease, Amyloidosis, Animals, Brain, Disease Models, Animal, Female, Gene Expression Regulation, Humans, Immune Tolerance, Immunity, Innate, Immunologic Memory, Inflammation, Male, Nervous System Diseases, Microglia, Stroke, Epigenesis, Genetic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
